FDA
-
BioMarin Drug Fails To Show Benefit In Inattention, Mood Complications Among Patients With PAH Deficiency
-
Cinqair Receives FDA Approval As Treatment For Severe Asthma
-
The FDA Cracks Down On Drug Abuse, Requires Warning Labels On Opioids
-
3-In-1 Test For Zika, Chikungunya and Dengue Gets Emergency FDA Approval
-
Video Of Man Urinating On Kellogg Factory Assembly Line Prompts FDA Investigation
-
Trial Of Genetically Engineered Mosquitoes To Fight Zika Gets Tentative FDA Approval
-
FDA Okays Pfizer's Lung Cancer Drug Xalkori For Expanded Use
-
FDA Settles With Drug Maker Amarin On Promotion Of Fish Oil Pill For Off-Label Use
-
FDA Wants Essure Contraceptive Implant To Come With Stronger Warning On Potential Risks
-
FDA Issues Recommendation To Prevent Zika Transmission Through Donated Human Tissues, Cells
-
US Now Has 147 Cases Of Zika Virus: CDC
-
US Senate Confirms Robert Califf To Run FDA
Most Popular
